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What Lies Ahead for 
Nanotechnology?
Nanotechnology,  the  engineering  of  func­
tional  materials  at  an  atomic  or  molecular 
scale,  has  been  among  the  fastest  growing 
fields of science and technology. Worldwide 
sales of products incorporating nanotechnolo­
gy are projected to total $2.6 trillion by 2014, 
according to a 2004 report from Lux Research 
titled  Sizing  Nanotechnology’s  Value  Chain. 
But with the increasing use of nano  materials 
in many consumer products has come grow­
ing  concern  about  potential  environmen­
tal, health, occupational, and general safety 
hazards. At the 2009 annual meeting of the 
American  Association  for  the  Advancement 
of  Science,  scientists  held  a  seminar  titled 
“Driving Beyond Our Nano­Headlights?” to 
discuss recent nanotoxicologic research as well 
as health and environmental policy implica­
tions of the use of nanomaterials.
Speaker Agnes Kane, a medical professor 
at Brown University, revisited the analogy 
between chrysotile asbestos fibers and carbon 
nanotubes  (CNTs),  a  concept  first  intro­
duced in 1998. In collaboration with fellow 
Brown University researcher Robert Hurt, 
Kane has compared the two materials and 
found  similarities  in  surface  area,  physical 
properties,  and  geometry,  raising  the  pos­
sibility that CNTs may show asbestos­like 
behavior in the human body. Also, using a 
newly designed cell culture model, Vanesa 
Sanchez, a graduate student in Kane’s labo­
ratory, found that very low doses of CNTs 
(1 µg/mL) appeared to cause lesions known 
as granulomas similar to what occurs with 
asbestos fibers. Moreover, the CNTs formed 
a cage­like structure that Kane suspects might 
promote granuloma formation.
Kane  also  cited  research  by  Ken 
Donaldson and colleagues of the University 
of Edinburgh in which the mesothelial lin­
ing of the mouse body cavity was exposed 
to  CNTs.  (In  humans,  asbestos  is  known 
to cause mesothelioma, a rare form of can­
cer  of  this  lining.)  As  Donaldson’s  group 
reported  in  the  July  2008  issue  of  Nature 
Nanotechnology,  this  exposure  resulted  in 
asbestos­like pathogenic effects that included 
inflammation and granuloma formation. 
Sanchez’s  new  cell  culture  model  is 
one of the few that can screen for potential 
adverse  health  effects  of  nanomaterials. 
Along these lines, the various challenges of 
conducting nanotoxicologic research are a 
central focus for Sally Tinkle, senior science 
advisor in the Office of the NIEHS Director. 
Tinkle said the shape and manufacture of a 
nanoparticle will have a profound impact 
on the particle’s reactivity, as well as how it 
interacts in the body. “Nanomaterials hold 
incredible promise to solve significant world 
problems, like the need for energy and clean 
water, but these new 
materials have novel 
physical and chemi­
cal  properties,  and 
we  don’t  know  yet 
what  their  interac­
tions with biological 
systems will be,” she 
said. 
Tinkle noted var­
ious  problems  with 
the  interpretation  of 
toxicologic  data  for 
nanomaterials. Citing 
correspondence pub­
lished in the February 
2007 issue of EHP by 
Günter Oberdörster 
and  colleagues  at  the 
University  of  Roch­
ester, she pointed out 
that toxicologic data 
could be interpreted 
differently depending 
on whether you looked at the nano  material’s 
mass or surface area. Moreover, in six com­
mon  toxicology  assays  on  the  same  nano­
material  sample  conducted  by  Nancy 
Monteiro­Riviere  and  colleagues  at  North 
Carolina State University, Tinkle noted that 
some  assays  showed  a  significant  effect  of 
exposure whereas others showed none. CNTs 
were also found to compromise the accuracy 
of the assays, but nanotoxicologists have yet 
to  identify  adequate  positive  and  negative 
controls that would better reveal the presence 
and effects of such interference.
Norris  Alderson,  associate  commis­
sioner for science at the U.S. Food and Drug 
Administration (FDA), raised a related issue 
in the manufacturing domain—that of guar­
anteeing  consistency  (primarily  in  terms  of 
size, shape, and purity of composition) from 
batch  to  batch  of  nanomaterial  to  ensure 
safety  and  efficacy.  “Let’s  say  you’ve  got  a 
nanoscale material for which the majority of 
particles  is  50  nm,”  said  Alderson.  “But  if 
there’s variation on both sides of that, how 
much can you vary that distribution and still 
procure a material with the same characteris­
tics or safety and efficacy?” 
Establishing appropriate standards for 
nanomaterial production is a salient con­
cern  for  Travis  Earles,  National  Science 
and Technology Council representative on 
the nanotechnology portfolio in the White 
House Office of Science and Technology 
Policy.  Earles  stated  that  such  standards 
were still a work in progress, both nation­
ally and internationally. “It’s a little bit of 
the Wild West in the standards develop­
ment side of things,” he said. “The stan­
dardization effort is quite crucial because 
it ultimately will be the context through 
which  we  can  successfully  or  unsuccess­
fully innovate nanotechnology into com­
mercial use.”
Despite  these  and  other  challenges, 
Earles was able to sound a note of optimism 
for scientists who are looking toward what­
ever might lie beyond the nano­  headlights: 
Federal  funding  allocated  specifically 
for  environmental,  health,  and  safety 
research  in  nanotechnology  has  grown 
from $34.8 million in 2005 to $58.6 mil­
lion in 2008. The multiagency National 
Nanotechnology Initiative anticipates that 
funding for the current year will increase 
to $76.4 million, well above the amount 
of  direct  investment  made  by  any  other 
country. –Graeme Stemp-Morlock
I am certain that nanotechnology holds huge promise. . . . But unless environ  mental, 
health, and safety issues are addressed in a way that fosters public understanding and 
support for nanotechnology, that potential is in jeopardy.
Senator Ron Wyden (D–OR), coauthor of the 21st Century Nanotechnology Research and Development Act
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Health and fitness products lead the way in terms of nanotech-
nology market growth. Between 8 March 2006 and 21 August 
2008, the number of “nano-enabled” health and fitness products 
on the market approximately quadrupled. 
Source: The Project on Emerging Nanotechnologies, http://www.nanotechproject.org/
inventories/consumer/Regulation
Cleaner Air,  
Longer Life
Since  the  1970s,  a  variety  of  measures 
for air pollution control have been intro­
duced in an effort to improve air quality 
throughout the United States. Many epi­
demiologic studies already support the view 
that substantial health benefits—including 
a lower risk of cardiopulmonary disease and 
death—are derived from better air quality. 
A  new  study  now  suggests  that  improve­
ments in U.S. air quality during the early 
1980s and late 1990s increased life expec­
tancy by several months. 
First  author  C.  Arden  Pope  III,  a 
Brigham Young University economics pro­
fessor, and colleagues Douglas W. Dockery 
and Majid Ezzati of the Harvard School of 
Public  Health  focused  on  particles  smaller 
than 2.5 micrometers in diameter (PM2.5), 
which  are  created  by  fuel  combustion  in 
vehicles  and  power  plants,  among  other 
sources. Pope says vehicle emissions tend to 
be the greatest local source of PM2.5, whereas 
power  plants  act  more  regionally  because 
pollutants from smoke stacks travel farther. 
Numerous  studies  have  linked  PM2.5 with 
increased respiratory and cardiovascular ill­
ness and premature death.
As  part  of  an  extended  analysis  of 
the  American  Cancer  Society  prospective 
cohort study, the team collected air­quality 
data from two 5­year time periods for 51 
U.S.  metro  areas  spanning  all  geographic 
regions of the nation. The first data set was 
collected  under  the  U.S.  Environmental 
Protection Agency’s (EPA) Inhalable Particle 
Monitoring  Network  from  1979  through 
1983.  The  second  set,  obtained  through 
the  EPA’s  National  Ambient  Air  Quality 
Standards  for  PM2.5,  was  collected  from 
1997  through  2001.  Statistical  regression 
models  were  used  to  evaluate  changes  in 
PM2.5 pollution and life expectancy, as well 
as to account for declines in cigarette smok­
ing and other factors known to affect life 
expectancy. 
As reported in the 22 January 2009 issue 
of  the  New  England  Journal  of  Medicine 
(NEJM),  the  team  found  that  when  PM2.5 
averaged over 24 hours dropped by 10 µg/m3 
between  the  two  study  periods,  life  expec­
tancy rose by about 7 months, with a range of 
6.6–12.1 months depending on the statistical 
model used. In those cities with the greatest 
drop in PM2.5 pollution (up to 14 µg/m3), life 
expectancy increased by almost 10 months. 
Overall, life expectancy increased by an aver­
age 2.7 years across the time frame studied. 
“Any way you model this reasonably, you 
get roughly the same results,” Pope says. A 
7­month increase in life expectancy “is stun­
ningly large when you consider no medical 
intervention took place,” he adds.  
A variety of national and local events led 
to reductions in PM2.5 since levels were first 
monitored in 1980. For instance, all cities 
in the study benefited from emission con­
trols on vehicles such as catalytic converters, 
which target pollutants that are precursors to 
PM2.5.  Regulation  of  wood­burning  stoves 
and fireplaces helped to clean up the air in 
the  Pacific  Northwest.  Until  now, 
communities nationwide could only 
assume  that  air­quality  regulations  would 
translate  into  increased  longevity.  “[This 
study] provides evidence that when actions 
are  taken  to  reduce  particulate  air  pollu­
tion in communities, it increases predicted 
life expectancy,” says environmental health 
professor Michael Brauer of the University 
of British Columbia, Vancouver. 
An even larger study of the same ACS 
cohort,  published  in  the  12  March  2009 
issue  of  NEJM  by  Pope  and  coauthors 
including Michael Jerrett of the University of 
California, Berkeley, followed nearly 450,000 
people for the same two­decade period but 
this time covered 96 U.S. metro areas. After 
analyzing  associations  between  the  risk  of 
death and levels of both ozone and PM2.5, 
the researchers concluded that “the risk of 
dying from a respiratory cause is more than 
three times as great in the metropolitan areas 
with the highest ozone concentrations as in 
those with the lowest ozone concentrations.” 
The report also reiterated the PM2.5 findings 
reported in the earlier NEJM article. 
The studies’ findings affirm the ben­
efits of regulatory efforts aimed at limiting 
exposure to both ozone and PM2.5. Of the 
first article, Dan Costa, EPA national pro­
gram director for air research, says, “This 
study  shows  that  PM  reductions  due  to 
responses  to  regulatory  actions  are  hav­
ing the impact desired—protecting public 
health. It provides plenty of winds to our 
sails that we are doing the right thing, and 
monies  spent  on  regulations  have  been 
worth it.” –Carol Potera
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u.s. Metro areas with the highest increase in  
life expectancy associated with PM2.5 Reductions
San Jose,C A
SanF rancisco, CA
LosA ngeles,C A
NewYork,N Y
Jersey City, NJ
  Reduction in  change in
  PM2.5 levels  life expectancy 
Metro area   (μg/m3)  (yr)
New York, NY  9  4.6
(4 counties)
Jersey City, NJ  4.7  4.5
(1 county)
San Francisco, CA  3.9  4.5
(3 counties)
San Jose, CA  3.2  4.2
(1 county)
Los Angeles, CA  6.6  4.1
(1 county)
Adapted  from:  Pope  CA  III,  Ezzati  M,  Dockery  DW.  Fine-particulate  air  pollution  and  life 
expectancy in the United States. N Engl J Med 360:376–386 (2009).
the 51 metro areas studied represented all  
geographic regions of the united statesi
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No Cap and Trade for Mercury 
On 23 February 2009, the U.S. Supreme Court 
upheld a lower court ruling to dismiss a Bush-
era appeal to support a controversial plan to 
establish a cap-and-trade program for mercury 
emissions. Most U.S. mercury pollution derives 
from coal-fired power plants, cement kilns, and 
incinerators. Utilities had supported the plan, 
believing it would foster innovation in pollution 
control; but critics argued that the tradable 
credits could enable polluters to actually increase 
their mercury emissions. The 1,100 facilities that 
would have benefited from the plan account 
for the largest unregulated industrial source of 
mercury pollution nationwide. 
Lead: Down but Not Out
Public health efforts to reduce lead exposure 
have resulted in a dramatic drop in average 
blood lead levels for U.S. children. A report in the 
March 2009 issue of Pediatrics now concludes 
that the number of children with blood lead 
above the CDC’s level of concern of 10 µg/dL 
has dropped by 84% since 1988. Although this 
estimate includes children in historically high-
risk groups, the report also notes that levels 
continue to be disproportionately elevated in 
these groups—notably non-Hispanic blacks 
living in housing built before 1950. Indeed, 
most U.S. children continue to have low-level 
lead exposure. Because no safe blood level has 
been established for lead, the authors point to 
the need to continue identifying and managing 
sources of lead, the single most important step 
in controlling blood lead levels. 
B Vitamins May Cut AMD Risk
Age-related macular degeneration (AMD) is the 
leading cause of blindness in elderly Americans. 
Recent  research  has  associated  levels  of 
homocysteine—a metabolic by-product linked 
with meat intake and blood vessel damage—
The Beat | by Erin E. Dooley
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RePRoductive toxicology
Study Associates PFOS and 
PFOA with Impaired Fertility
Recent  decades  have  seen  a  substantial  decline  in  the  number  of 
children being born to women in developed countries. Much of this 
decline is likely attributable to sociocultural changes and increased 
access to birth control. But some studies suggest that exposure to 
environmental  pollutants  may  play  a  role,  perhaps  by  impairing 
fecundity, the ability to bear live children. Now a study by research­
ers at the University of California, Los Angeles (UCLA) has found 
that women who took longer to become pregnant were more likely 
to have higher blood levels of two common perfluorinated chemicals, 
perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA). 
PFOS and PFOA are persistent manmade pollutants widely found 
in fabrics, carpets, food packaging, shampoo, nonstick cookware, insec­
ticides, fire­fighting foam, and other household products, as well as in 
industrial surfactants and emulsifiers. Potential major sources of PFOA 
in the environment include the degradation of fluorinated alcohols used 
in these products. Animal studies have associated both PFOS and PFOA 
with increased pregnancy losses and disruption in sex hormone homeo­
stasis  and  sexual  maturation.  Although  previous  studies  have  linked 
pollutants such as pesticides and polychlorinated biphenyls with delayed 
time to pregnancy, the UCLA study is the first to demonstrate a similar 
relationship with perfluorinated chemicals. 
In the current study, the researchers measured maternal blood con­
centrations of PFOA and PFOS in 1,240 pregnant women who partici­
pated in the Danish National Birth Cohort from 1996 to 2002. Blood 
samples were drawn from weeks 4 through 14 of pregnancy, and women 
were asked at approximately week 12 how long it had taken to conceive 
and whether the pregnancy was planned. 
Median maternal blood levels of PFOA and PFOS were 5.3 ng/mL 
and 33.7 ng/mL, respectively. Women were assigned to four quartiles of 
exposure, with the lowest quartile serving as the reference group. Women 
in the three higher quartiles were about twice as likely to have taken 
longer than 12 months to achieve pregnancy or to have required infertil­
ity treatments to become pregnant, compared with the reference group. 
They were also slightly more likely to report irregular menstrual periods. 
The results, which are slated to appear in the May 2009 issue of Human 
Reproduction, were published online 28 January 2009. 
The blood concentrations measured in the Danish women were 
similar to those found in other Western populations, “so the findings 
probably  [are  applicable  to]  other  affluent  Caucasian  societies,”  says 
study leader Jørn Olsen, chairman of the Department of Epidemiology 
at the UCLA School of Public Health. However, “it’s important for 
someone else to replicate the study in another group of women,” he 
notes. It’s unknown how PFOS and PFOA may contribute to infertility; 
it is possible the chemicals interfere with sex hormones, delay ovulation, 
or contribute to unrecognized miscarriage (the authors of the 2004 text 
Clinical Gynecologic Endocrinology and Infertility, 7th Edition estimate that 
20–40% of women miscarry before they even realize they are pregnant). 
The UCLA study “is the first study ever in humans on this topic, 
to the best of my knowledge,” says David Savitz, director of the Disease 
Prevention  and  Public  Health  Institute  at  Mount  Sinai  School  of 
Medicine in New York City. The study “gives a limited first look at 
the issue,” Savitz says, “but does encourage continued evaluation of the 
reproductive toxicity of PFOA and PFOS.”
In  2006  the  U.S.  Environmental  Protection  Agency  (EPA)  asked 
manufacturers to voluntarily reduce PFOA emissions and product content 
by 95% no later than 2010 and to eliminate the chemical by 2015. Olsen 
says the new data could help strengthen arguments to eventually regulate 
PFOA and PFOS or phase them out. Meanwhile, a study by Antonia M. 
Calafat and colleagues at the Centers for Disease Control and Prevention, 
published in the November 2007 issue of EHP, found significant reduc­
tions in human blood levels of PFOA and PFOS (25% and 32%, respec­
tively) from 2003 and 2004 compared with data for 1999 through 2000. 
The authors of that study suggested that successful efforts by government 
and industry to reduce usage and emissions of these chemicals are the most 
likely reason for the downward trends. –Carol PoteracheMical testing  
Developmental Immunotoxicity 
in Review
Much of the current knowledge regarding the adverse effects of environ­
mental pollutants is based on laboratory evaluations performed using adult 
animals. But new clues now suggest that many diseases—including aller­
gies, asthma, type 1 diabetes, atherosclerosis, leukemia, and autism—may 
originate in immune system damage caused by exposure to toxicants in 
early life, possibly even before birth. The routine conduct of safety screens 
on adult animals misses potential windows of unparalleled immune vul­
nerability in early life, writes immunotoxicology professor Rodney Dietert 
of the Cornell University College of Veterinary Medicine, in an invited 
review of the developmental immunotoxicity (DIT) literature published 
in the January 2009 issue of Chemical Research in Toxicology. 
A central tenet of DIT is that the prenatal and perinatal immune sys­
tems are uniquely sensitive to toxic insult. For instance, prenatal exposure 
to dioxin causes immunotoxicity at a dose approximately 100­fold lower 
than the exposure that causes damage in adults, as Dietert and colleagues 
reported in the January 2006 Journal of Toxicology and Environmental 
Health, Part B Critical Reviews. Moreover, different immune processes 
are at work in different life stages. Disease­fighting T cells, for example, 
develop in the thymus during early life, but by adulthood are produced 
largely  in  other  tissues.  Also,  some  chemicals  produce  only  transient 
immune system changes with adult exposure but produce lasting changes 
with fetal or early neonatal exposure. 
Some safety screens are conducted across the life span, but DIT testing 
is usually initiated only after adult data suggest immuno  toxicity. “Dietert’s 
review makes the important point that DIT testing is a complementary 
approach to toxicology testing in adult immune systems and should be 
considered when developing immune systems are likely to be exposed 
to xenobiotics,” says Fred Miller, chief of the NIEHS Environmental 
Autoimmunity Group. “However, DIT testing raises important ques­
tions regarding the appropriate doses, periods of exposure, and routes of 
exposure that should be tested at different phases of immune system devel­
opment, all of which would depend on the expected human exposure.” 
Such questions regarding how to implement DIT testing have been 
debated worldwide for nearly a decade. But further work is needed to 
refine the details of screening protocols for DIT testing, says Susan Makris, 
a toxicologist with the Environmental Protection Agency. Screening pro­
cedures may need to be tailored to individual chemicals. “For example, 
consideration must be given to the pharmacokinetics of the chemical [how 
the chemical is metabolized] in terms of how it’s being administered,” she 
says. Otherwise, testing may not closely simulate real­world exposures. 
Michael  Holsapple,  executive  director  of  the  Health  and 
Environmental  Sciences  Institute  at  the  International  Life  Sciences 
Institute in Washington, DC, says that what is really needed is develop­
ment and implementation of DIT testing protocols, including studies 
to determine “triggers” that would prompt the implementation of such 
protocols. One such trigger might be the ability of a test compound to 
cross the placenta or be secreted in milk. “If the fetal or neonatal exposure 
seems so low as to be basically inconsequential, this could mean that DIT 
studies would be of little use in assessing risk,” he explains. “These and 
many other considerations would seem to challenge the premise that 
DIT testing should become a global policy.” 
Once protocols are complete, regulatory change must occur across 
many agencies. “But even where there is agreement on what kind of test­
ing needs to be done, implementing those studies, chemical by chemical, 
will be very much driven by the regulations that are enforced for each of 
those groups,” says Makris. 
Perhaps the biggest obstacle to normalizing DIT testing is that of 
finding reliable ways to generate clear evidence for an impact of early­
life exposures on human health outcomes in adult life. “Discovering 
and characterizing the connections between chemical exposure during 
early­life stages and disease onset and progression during later­life stages 
will only come from developing and implementing DIT testing proto­
cols,” says Holsapple. “And the complexity of these protocols, if they are 
to cover the full gamut suggested by Dr. Dietert, will be considerable 
indeed.” –Angela Spivey
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with elevated risk of AMD. A report in the 23 
February 2009 Archives of Internal Medicine 
now suggests that treatment with certain B 
vitamins—namely B6, B12, and folic acid—may 
ward off AMD by lowering homocysteine levels. 
Women assigned to the B-vitamin group had a 
statistically significant 35–40% decreased risk of 
AMD compared with controls. The association 
began to show up after about 2 years and 
persisted throughout the 7-year trial period. 
Winners in Cooling the Planet
The winners of the U.K. Institution of Mechanical 
Engineers Cooling the Planet challenge were 
announced 5 March 2009. The competition was 
meant to inspire young scientists to develop 
engineering methods to reduce atmospheric 
greenhouse gas levels. The winner in the 
category of Mitigation—who also won the 
overall competition—proposed converting 
organic waste from landfills to biochar through 
a network of pyrolysis plants; the biochar, in 
turn, would enrich soils and sequester carbon 
[for more on biochar, see EHP 117:A70–A73 
(2009)]. The winner of the Geoengineering 
category proposed a system of artificial “trees” 
covered with chemical scrubbers. The scrubbers 
would use lye to remove CO2 from surrounding 
air. Calcium oxide would remove the CO2 
from the scrubbers, after which the developers 
propose underground storage. 
A U.S. Ban for BPA?
Growing evidence links bisphenol A (BPA), 
an endocrine disruptor, to a range of adverse 
health effects. On 13 March 2009 companion 
bills were introduced into the U.S. House and 
Senate proposing to ban the use of BPA in all 
food and drink containers. Days earlier, 6 U.S. 
baby bottle  manufacturers had announced 
they have stopped or plan to stop using BPA 
in bottles sold in the United States. However, 
at least one of the manufacturers has publicly 
stated its intention to continue selling BPA-
containing baby bottles overseas.  
EPA to Monitor Air Near Schools
Recent media coverage (e.g., EHP 116:A474 
[2008]) has called attention to high levels of air 
pollution found around at least one in three U.S. 
schools. On 2 March 2009, the EPA announced 
a novel program to measure air pollution near 
100 at-risk schools across the country, with 
monitoring to be performed by state, local, 
and tribal government personnel. The agency 
expects monitoring to begin at some schools 
as early as April 2009, and results will be made 
available to the public. Because children are 
more vulnerable than adults to the toxic effects 
of many pollutants, strategies to minimize their 
day-to-day exposure levels are urgently needed.
Forum
Environmental Health Perspectives  •  v o l u m e  117 | n u m b e r  4 | April 2009  A149
Concept for artificial trees to 
capture atmospheric CO2